Exclusive

Latest

Approved PATHWAYS Trial for Gender-Questioning Children Sets Minimum Age of 11

The Medicines and Healthcare products Regulatory Agency (MHRA) has introduced new minimum age requirements for participants in the PATHWAYS Trial, a landmark study examining the effects of puberty blockers in young people experiencing gender incongruence. As researchers seek to address evidence gaps identified by the Cass Review, the study could play a pivotal role in shaping future NHS policy and clinical decision-making on gender-related healthcare.

Latest

Approved PATHWAYS Trial for Gender-Questioning Children Sets Minimum Age of 11

The Medicines and Healthcare products Regulatory Agency (MHRA) has introduced new minimum age requirements for participants in the PATHWAYS Trial, a landmark study examining the effects of puberty blockers in young people experiencing gender incongruence. As researchers seek to address evidence gaps identified by the Cass Review, the study could play a pivotal role in shaping future NHS policy and clinical decision-making on gender-related healthcare.

Subscribe to our newsletter for your free digital copy of the journal!

Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.

Newsletter Signups
?
?

We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.

Never miss an issue by subcribing to our newsletter!

Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.

We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.

Never miss an issue by subcribing to our newsletter!

Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.

Newsletter Signups
?
?

We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.

Newsletter Signup

Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.

Newsletter Signups
?
?

We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.